Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,...
Reexamination Certificate
2011-07-12
2011-07-12
Kemmerer, Elizabeth C. (Department: 1646)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
C424S133100, C424S145100
Reexamination Certificate
active
07976839
ABSTRACT:
A transgenic non-human animal of the species selected from the group consisting of avian, bovine, ovine and porcine having a transgene which results in disrupting the production of and/or activity of growth differentiation factor-11 (GDF-11) chromosomally integrated into the germ cells of the animal is provided. Also provided are methods for making such animals, and methods of treating animals, including humans, with antibodies or antisense directed to GDF-11. The animals so treated are characterized by increased muscle tissue and bone tissue.
REFERENCES:
patent: 5585479 (1996-12-01), Hoke et al.
patent: 5639638 (1997-06-01), Wozney et al.
patent: 5914234 (1999-06-01), Lee et al.
patent: 5994618 (1999-11-01), Lee et al.
patent: 6008434 (1999-12-01), Lee et al.
patent: WO 92/00382 (1992-01-01), None
patent: WO 93/05172 (1993-03-01), None
patent: WO 94/21681 (1994-09-01), None
patent: WO 94/26892 (1994-11-01), None
patent: WO 96/01845 (1996-01-01), None
patent: WO 97/41880 (1997-11-01), None
patent: WO 99/06559 (1999-02-01), None
patent: WO 99/40181 (1999-08-01), None
patent: WO 00/06716 (2000-02-01), None
Elkasrawy et al., J. Musculoskelet. Neuronal Interact., 2010, vol. 10(1):56-63.
Aszodi et al., “Mouse models for extracellular matrix diseases”,J.Mol.Med., 76:238-252 (1998).
Biga et al., “The isolation, characterization, and expression of a novel GDF11 gene and a second myostatin form in zebrafish,Danio rerio”, Comparative Biochemistry&Physiology, Part B 141:218-230 (2005).
Capecchi M.R., “Targeted gene replacement”,Scientific American, 270(3):34-41 (1994).
Dudley et al., “A requirement for bone morphogenetic protein-7 during development of the mammalian kidney and eye”,Genes and Development, 9(22):2795-2807 (1995).
Gad et al., “Axis development: The mouse becomes a dachshund”,Current Biology, 9:R783-R786 (1999).
Garner et al., “Gdf11is a negative regulator of chondrogenesis and myogenesis in the developing chick limb”,Developmental Biology, 229:407-420 (2001).
Horan et al., “Homeotic transformation of cervical vertebrae inHoxa-4mutant mice,”Proc. Natl. Acad. Sci. USA., 91(26):12644-12648 (1994).
Iwata et al., “Bone morphogenetic protein-induced muscle- and synovium-derived cartilage differentiation in vitro”,Clin. Orthop. Relat. Res., 296:295-300 (1993).
Lee, “Expression of growth/differentiation factor 1 in the nervous system: Conservation of a bicistronic structure”,Proc. Natl. Acad. Sci. USA, 88:4250-4254 (1991).
Lee, “Identification of a Novel Member (GDF-1) of the Transforming Growth Factor-.beta. Superfamily”,Molecular Endocrinology, 4(7):1034-1039 (1990).
Massague, “The TGF-.beta. Family of Growth and Differentiation Factors”,Cell, 49:437-38, 1987.
McPherron et al., “Regulation of anterior/poaterior patterning of the axial skeleton by growth/differentiation factor 11”,Nature Genetics, 22:260-264 (1999).
Moens et al. “Defects in heart and lung development in compound heterozygotes for two different targeted mutations at the N-myclocus”,Development, 119:485-499 (1993).
Moreadith et al. Gene targeting in embryonic stem cells: the new physiology and metabolism,J. Mol. Med., 75(3):208-216 (1997).
Mullins et al., “Perspectives series: molecular medicine in genetically engineered animals”,J. Clin. Invest., 98(11) Supplement:S37-S40 (1996).
Sampath et al., “Drosophila transforming growth factor beta superfamily proteins induce endochondral bone formation in mammals,”Proc. Natl. Acad. Sci. USA., 90(13):6004-6008 (1993).
Wagner et al., “Transgenic animals as models for human disease”,Clin.&Exper. Hypertension, 17(4):593-605 (1995).
Wall R.J., “Transgenic livestock: progress and prospects for the future”,Theriogenology, 45:57-68 (1996).
Lee Se-Jin
McPherron Alexandra C.
DLA Piper (LLP) US
Johns Hopkins University School of Medicine
Kemmerer Elizabeth C.
Xie Xiaozhen
LandOfFree
Growth differentiation factor-11 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Growth differentiation factor-11, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Growth differentiation factor-11 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2724538